Home Tags Neurodegenerative Diseases

Neurodegenerative Diseases Related Content

cognitive impairment

Ageing: Detection of cognitive impairment using voice analysis technology

Shinichi Tokuno from Voice Analysis and Measurement of Pathophysiology, Department of Bioengineering, at the University of Tokyo, shares with us what we need to know about the detection of cognitive impairment with the benefit of voice analysis technology concerning the ageing of people globally.
Five rare diseases, Alice in Wonderland Syndrome

Five rare diseases you never knew existed

Learn about these five rare diseases to support governments, scientists and healthcare professionals to find treatments.
breakthrough in stroke treatment, invasive surgery

Researchers make breakthrough in stroke treatment

An international research team has made a breakthrough in stroke treatment, with a drug that could stop brain swelling without invasive surgery.
difference between dementia and alzheimer’s

Understanding the difference between Dementia and Alzheimer’s

Ella Hendrix, Writer, takes it back to basics and explains the difference between Dementia and Alzheimer's disease
cbd oil revolution

CBD oil revolution: Introducing what it is and why the hype?

Open Access Government delve into the CBD oil revolution in this introduction to CBD which explores the difference between CBD and THC, as well as a range of benefits and safety precautions for cannabidiol use in cancer patients and pregnant women.
traumatic brain injury, disease control

Controlling and preventing diseases: A focus on traumatic brain injury

The work of the Centers for Disease Control and Prevention, within the U.S. Department of Health & Human Services is examined here, with a special focus on traumatic brain injury.
neurodegenerative diseases, protein

A brief overview of advances in neurodegenerative diseases

Cecilia Van Cauwenberghe from Frost & Sullivan’s TechVision Group, provides an overview of Neurodegenerative Diseases.
Dementia as a public health issue

Dementia as a public health issue in Hong Kong

Cecilia Van Cauwenberghe from Frost & Sullivan’s TechVision Group, examines dementia as a public health issue in Hong Kong.
vitamin b12

Vitamin B12 and brain health of older people

Here, Professor Timothy Kwok discusses the impact of vitamin B12 on the brain health of older people.

Environmental exposures during early life influence adult disease risk

Carolyn R. Klocke and Pamela J. Lein discuss how an individual’s experiences during early life can influence their risk for disease as an adult.
genetic brain disease, Hereditary spastic paraplegias

Researchers discover new genetic brain disease

Manchester researchers have contributed towards the discovery of a genetic brain disease which can cause paraplegia and epilepsy in sufferers.

Intramembrane proteases in neurodegenerative diseases

Prof Dr Regina Fluhrer, from the University of Augsburg, explains how intramembrane proteases have been implicated in the emergence of neurodegenerative diseases.
Alzheimer's disease research

Supporting vital Alzheimer’s disease research in the U.S and beyond

The work of the National Institute on Aging (NIA) is placed into focus here, with examples of how they are supporting vital Alzheimer’s disease research in the U.S and further afield.
Huntington's disease

Huntington’s disease (HD): Is there hope on the horizon?

Dr Gerry Morrow shares his thoughts on the rare, progressive neurodegenerative illness, Huntington’s disease (HD).
neurodegenerative diseases

New treatments for neurodegenerative diseases

Professor Dame Pamela Shaw explains how the National Institute for Health Research (NIHR) supports experimental medicine and translational research in neurodegenerative diseases.
degenerative diseases

UK-Japanese partnership to tackle degenerative diseases

Medical researchers in Britain and Japan are to join forces in the fight to advance research into treatments for degenerative diseases.
neurodegenerative disorders

Treatment and diagnosis of neurodegenerative disorders

Andrea Varrone studies the importance of molecular imaging to provide personalised medicine and improve care for patients with neurodegenerative disorders
cellular pathways

Intramembrane proteases: Regulators of cellular pathways

Prof Dr Regina Fluhrer from Biomedical Center (BMC), Ludwig Maximilians University of Munich (LMU) & German Center for Neurodegenerative Diseases (DZNE) shares her expertise on the field of intramembrane proteases, focussing on regulation of cellular pathways
neurodegenerative diseases

Tackling neurodegenerative diseases including Alzheimer’s

The work of the EU Joint Programme – Neurodegenerative Disease Research (JPND) which aims to tackle the challenge of these diseases, in particular, Alzheimer’s, is discussed here
neurodegenerative disorders

Early diagnosis of neurodegenerative disorders: Where are we now?

Dr Gerry Morrow shares his thoughts on the current state of play when it comes to the early diagnosis of neurodegenerative disorders, and asks the questions, can we screen, and should we screen?

Follow Open Access Government